PP_1170x120_10-25-21

Dan Leonard is president and chief executive officer of the Association for Accessible Medicines.

Generics’ value goes beyond price to quality, efficacy

Generics’ value goes beyond price to quality, efficacy

U.S. patients may not fully understand the complex manufacturing and market dynamics that allow them to pay an average of just $6.61 for their generic prescription medicines at the pharmacy counter. That’s why tens of millions of Americans entrust their health to generics and biosimilars. In fact, fully 90% — nearly 4 billion in 2020

AAM warns Build Back Better Act threatens patient access

AAM warns Build Back Better Act threatens patient access

WASHINGTON — The Association for Accessible Medicines president and CEO Dan Leonard issued the following statement regarding the Build Back Better Act: “The House-passed Build Back Better Act (H.R. 5376) threatens the only segment of our health care system that consistently drives prices down for patients.  For more than three decades, generic medicines have provided

Patients paying less for generic medicines

Patients paying less for generic medicines

NEW YORK — FDA-approved generic and biosimilar medicines are key to America’s health care, filling nine out of ten prescriptions dispensed in the United States. Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM), recently partnered with YourUpdate TV on a nationwide media tour to discuss why reliable, affordable, high-quality prescription medication

Changes to Medicare Part D threaten savings for seniors

Changes to Medicare Part D threaten savings for seniors

On the tiering issue for generics, answering the question: “Why are your Part D patients paying higher co-pays for low-cost generics?” The availability of generic drugs has long meant safe, effective and affordable access to medicines for America’s patients. Generics are an integral component of patient care, offering quality, lower-cost versions of prescription drugs approved

AAM issues statement on the anniversary of USMCA

AAM issues statement on the anniversary of USMCA

WASHINGTON – On the occasion of the one-year anniversary of the U.S.-Mexico-Canada Agreement coming into force, the Association for Accessible Medicines (AAM) releases the following statement: “One year ago today, the U.S.-Mexico-Canada Agreement set the standard for a modern trade agreement. By balancing support for pharmaceutical innovation with generic and biosimilar competition, USMCA is a

Seven recommendations for holding down drug prices

Seven recommendations for holding down drug prices

Americans consistently say congressional action is needed to lower the price of the medicines we need to stay healthy and live productively. In a January 2021 Politico/Harvard T.H. Chan School of Public Health survey, drug prices came second only to COVID-19 relief as the issue we care most about, with 95% of Democrats and 82%